Status:
RECRUITING
Adding Magnesium Sulfate to Local Anesthetic in Combined Pectoral Nerve and Stellate Ganglion Block for Postoperative Pain Control After Modified Radical Mastectomy
Lead Sponsor:
Cairo University
Conditions:
Magnesium Sulfate
Local Anesthetic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We aim to study the effect of adding magnesium sulfate as an adjuvant to the local anesthetic used in the combined Pectoralis Nerve Block II (PECS II) and stellate ganglion block for postoperative pai...
Detailed Description
Post-operative pain from breast surgery can be controlled by regular pain medications such as paracetamol, non-steroidal anti-inflammatory (NSAIDs), and narcotics. Nerve blocks are commonly used as mu...
Eligibility Criteria
Inclusion Criteria:
- Age ≥18 years.
- Female gender.
- American Society of Anesthesiologists (ASA) physical status II or III.
- Patients scheduled for elective modified radical mastectomy for breast cancer.
- Body mass index (BMI): > 20 kg/m2 and < 40 kg/m2.
Exclusion Criteria:
- Bleeding tendency due to coagulopathy,
- Patients with opioid dependence or alcohol or drug abuse,
- Significant liver and renal sufficiency
- Patients with psychiatric illnesses that prevent them from proper perception and assessment of pain.
- Local infection at the site of the block.
- Known hypersensitivity or allergy to magnesium sulfate or local anesthetics.
- Patients with chronic pain syndromes or pre-existing neuropathic pain conditions.
- Pregnant or lactating individuals.
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06815887
Start Date
January 15 2024
End Date
July 31 2025
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 12613